SCHEMBL4358703

SCHEMBL4358703

O=C1N=C(N2CCOCC2)S/C1=C\c1ccc(C(F)(F)F)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
ALDH1A1 P00352 6/20 0.62
NPSR1 Q6W5P4 2/20 0.62
CYP1A2 P05177 2/20 0.62
CYP2C19 P33261 2/20 0.62
MAPK1 P28482 1/20 0.62
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
HPGD P15428 1/20 0.56
GRIN1 Q05586 1/20 0.55
GRIN2B Q13224 1/20 0.55
NPC1 O15118 3/20 0.54
DCTPP1 Q9H773 1/20 0.54
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
GPR55 Q9Y2T6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358705 1.00 MAPT (0.62) MAPTALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4354235 0.88 ALDH1A1 (0.80) MAPTALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4354232 0.88 ALDH1A1 (0.80) MAPTALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4351235 0.87 MAPT (0.63) MAPTALDH1A1NPSR1MAPK1MEN1
SCHEMBL4351239 0.87 MAPT (0.63) MAPTALDH1A1NPSR1MAPK1MEN1
SCHEMBL4354242 0.86 KMT2A (0.63) MAPTALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4354246 0.86 KMT2A (0.63) MAPTALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4348551 0.86 MAPT (0.62) MAPTALDH1A1NPSR1MAPK1MEN1
SCHEMBL4348552 0.86 MAPT (0.62) MAPTALDH1A1NPSR1MAPK1MEN1
Bromide SCHEMBL4356134 0.85 KMT2A (0.62) MAPTALDH1A1NPSR1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MAPT 1470/4885ALDH1A1 284/4885NPSR1 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.